| Dr Yukmei Rebecca Lam, MD | |
|
7310 W Lincoln Hwy, Crown Point, IN 46307-9528 | |
| (219) 322-4673 | |
| (219) 322-5298 |
| Full Name | Dr Yukmei Rebecca Lam |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 22 Years |
| Location | 7310 W Lincoln Hwy, Crown Point, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861429912 | NPI | - | NPPES |
| 200858890 | Medicaid | IN | |
| 000000721915 | Other | IN | ANTHEM TRADITIONAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 01061983A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franciscan Health Crown Point | Crown point, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Physician Network | 3072790682 | 989 |
News Archive
The U.S. Food and Drug Administration today approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegaspargase chemotherapy drugs used to treat ALL.
Disorders caused by a leaky vasculature are more common than most people think. Despite ICU treatment, one third of the 27 million patients globally that suffer from sepsis, and up to 20% of the more than 5 million US patients with congestive heart failure die every year from their condition.
PaxVax Inc., a specialty vaccine company with a commercial focus on travel and biodefense and a social mission to ensure global access to its vaccines, today announced that it has entered into a research and development collaboration with the University of California, San Diego to develop a combination vaccine to prevent genital herpes simplex virus (HSV) infections.
Several opinion pieces have been published in recognition of One Billion Rising, a global campaign calling for an end to violence against women and gender equality.
› Verified 9 days ago
| Entity Name | Franciscan Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225327984 PECOS PAC ID: 3072790682 Enrollment ID: O20110608000486 |
News Archive
The U.S. Food and Drug Administration today approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegaspargase chemotherapy drugs used to treat ALL.
Disorders caused by a leaky vasculature are more common than most people think. Despite ICU treatment, one third of the 27 million patients globally that suffer from sepsis, and up to 20% of the more than 5 million US patients with congestive heart failure die every year from their condition.
PaxVax Inc., a specialty vaccine company with a commercial focus on travel and biodefense and a social mission to ensure global access to its vaccines, today announced that it has entered into a research and development collaboration with the University of California, San Diego to develop a combination vaccine to prevent genital herpes simplex virus (HSV) infections.
Several opinion pieces have been published in recognition of One Billion Rising, a global campaign calling for an end to violence against women and gender equality.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yukmei Rebecca Lam, MD Po Box 781076, Detroit, MI 48278-1076 Ph: (317) 528-4800 | Dr Yukmei Rebecca Lam, MD 7310 W Lincoln Hwy, Crown Point, IN 46307-9528 Ph: (219) 322-4673 |
News Archive
The U.S. Food and Drug Administration today approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegaspargase chemotherapy drugs used to treat ALL.
Disorders caused by a leaky vasculature are more common than most people think. Despite ICU treatment, one third of the 27 million patients globally that suffer from sepsis, and up to 20% of the more than 5 million US patients with congestive heart failure die every year from their condition.
PaxVax Inc., a specialty vaccine company with a commercial focus on travel and biodefense and a social mission to ensure global access to its vaccines, today announced that it has entered into a research and development collaboration with the University of California, San Diego to develop a combination vaccine to prevent genital herpes simplex virus (HSV) infections.
Several opinion pieces have been published in recognition of One Billion Rising, a global campaign calling for an end to violence against women and gender equality.
› Verified 9 days ago
Mary Eileen Mccormack, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 800 W Burrell Dr, Crown Point, IN 46307 Phone: 219-663-9913 Fax: 219-663-9923 | |
Omar Mostafa Abuzeid, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 297 W Franciscan Dr Ste 104, Crown Point, IN 46307 Phone: 219-213-2280 Fax: 219-213-2281 | |
John Thomas King, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1201 S Main St, Crown Point, IN 46307 Phone: 219-757-6101 Fax: 219-757-6336 | |
Merit D Lemke, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9301 Connecticut Dr, Crown Point, IN 46307 Phone: 219-796-4060 Fax: 219-756-8007 | |
Jeannine M Mcmahon, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 12750 St Francis Dr, Crown Point, IN 46307 Phone: 219-757-6331 Fax: 219-757-6481 | |
Dr. Zachary Christopher Dobbin, M.D., PH.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10215 Broadway Ste 207, Crown Point, IN 46307 Phone: 219-661-6171 Fax: 219-703-6836 | |
Kelli Barber Crowley, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7310 W Lincoln Hwy, Crown Point, IN 46307 Phone: 219-322-4673 Fax: 219-322-5298 |